TNSN05156A1 - 1-AZABICYCLO [2,2,2] OCTYL-SUBSTITUTED FURO [2,3-C] PYRIDINYLCARBOXAMIDE CRYSTALLINE FUMARATED SALTS, COMPOSITIONS CONTAINING SAME, AND THEIR PREPARATION - Google Patents

1-AZABICYCLO [2,2,2] OCTYL-SUBSTITUTED FURO [2,3-C] PYRIDINYLCARBOXAMIDE CRYSTALLINE FUMARATED SALTS, COMPOSITIONS CONTAINING SAME, AND THEIR PREPARATION

Info

Publication number
TNSN05156A1
TNSN05156A1 TNP2005000156A TNSN05156A TNSN05156A1 TN SN05156 A1 TNSN05156 A1 TN SN05156A1 TN P2005000156 A TNP2005000156 A TN P2005000156A TN SN05156 A TNSN05156 A TN SN05156A TN SN05156 A1 TNSN05156 A1 TN SN05156A1
Authority
TN
Tunisia
Prior art keywords
salts
azabicyclo
preparation
compositions containing
pyridinylcarboxamide
Prior art date
Application number
TNP2005000156A
Other languages
French (fr)
Inventor
Jon Gordon Selbo
Bradley Dee Hewitt
David Warner Rappath
Donn Gregory Wishka
Ahmad Yahya Sheikh
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2003/005607 external-priority patent/WO2004052894A1/en
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of TNSN05156A1 publication Critical patent/TNSN05156A1/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention propose des sels consistant en fumarates de N-(1-azabicyclo (2.2.2) oct-3-yl) furo (2,3-c)pyridine-5-carboxamide, des compositions les contenant, leurs mélanges racémiques ou leurs énantiomères purs, et leur préparation. Les sels consistant en fumarates sont utiles pour traiter des maladies ou affections dans lesquelles on sait qu' alpha 7nAChR est impliqué. Formule (I).The present invention provides salts of N- (1-azabicyclo (2.2.2) oct-3-yl) furo (2,3-c) pyridine-5-carboxamide fumarates, compositions containing them, racemic mixtures thereof or their pure enantiomers, and their preparation. Fumarate salts are useful for treating diseases or conditions in which alpha 7nAChR is known to be involved. Formula (I).

TNP2005000156A 2003-12-01 2005-06-06 1-AZABICYCLO [2,2,2] OCTYL-SUBSTITUTED FURO [2,3-C] PYRIDINYLCARBOXAMIDE CRYSTALLINE FUMARATED SALTS, COMPOSITIONS CONTAINING SAME, AND THEIR PREPARATION TNSN05156A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AP2005003326A AP2005003326A0 (en) 2003-12-01 2003-12-01 Crystalline fumarate salts of 1-azabiccloÄ2.2.2Üoct substituted furoÄ2,3-cÜpyridinyl carboxamide andcompositions and preparations thereof.
PCT/IB2003/005607 WO2004052894A1 (en) 2002-12-06 2003-12-01 Crystalline fumarate salts of 1-azabicyclo[2.2.2]oct substituted furo[2,3-c]pyridinyl carboxamide and compositions and preparations thereof

Publications (1)

Publication Number Publication Date
TNSN05156A1 true TNSN05156A1 (en) 2007-05-14

Family

ID=39684532

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2005000156A TNSN05156A1 (en) 2003-12-01 2005-06-06 1-AZABICYCLO [2,2,2] OCTYL-SUBSTITUTED FURO [2,3-C] PYRIDINYLCARBOXAMIDE CRYSTALLINE FUMARATED SALTS, COMPOSITIONS CONTAINING SAME, AND THEIR PREPARATION

Country Status (2)

Country Link
AP (1) AP2005003326A0 (en)
TN (1) TNSN05156A1 (en)

Also Published As

Publication number Publication date
AP2005003326A0 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
MA27604A1 (en) CRYSTALLINE FURAR SALTS OF FURO [2,3-C] PYRIDINYLCARBOXAMIDE WITH SUBSTITUTE 1- AZABICYCLO [2.2.2] OCTYL, COMPOSITIONS CONTAINING THEM, AND THEIR PREPARATION
MA27808A1 (en) QUINOLINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE
TNSN99073A1 (en) NOVEL PYRAZOLOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TNSN98053A1 (en) NOVEL PYRAZOLOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM.
PT1678166E (en) Protein kinase inhibitors
TNSN00198A1 (en) COMPOUNDS FOR NEW INHIBITORS OF cGMP PDE, PROCESS FOR THEIR PREPARATION AND FORMULATIONS CONTAINING THEM.
TNSN04156A1 (en) SUBSTITUTED PYRIDINONES AS MODULATORS OF MAP-KINASE P38
MA27957A1 (en) DERIVATIVE QUINOLINONE AGENTS AS TYROSINE KINASE INHIBITORS
MY140872A (en) 5,7-diaminopyrazolo[4,3-d]pyrimidines with pde-5 inhibitory activity, compositions containing such derivatives and the use of such derivatives in the treatment of hypertension and other disorders
HUP0401538A2 (en) Novel derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and pharmaceutical compositions containing same
AP1860A (en) Aryl fused azapolycyclic compounds.
LU90053I2 (en) Topotecan and its pharmaceutically acceptable salts and derivatives (Hycamtin)
TNSN01077A1 (en) NEW TROPANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
TNSN05165A1 (en) PYRROLOPYRIMIDINE DERIVATIVES
TNSN04151A1 (en) NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS
DE602004007239D1 (en) 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL DERIVATIVES FOR USE AS PDE7 INHIBITORS
HUP9802678A2 (en) Bicyclic amino derivatives and pgd2 antagonist containing the same
TNSN04137A1 (en) NOVEL HETEROCYCLIC COMPOUNDS ACTIVE AS BETA-LACTAMASES INHIBITORS
TW200502221A (en) Novel lactams and uses thereof
MXPA05010883A (en) Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin.
TNSN07167A1 (en) SUBSTITUTED INDOLES, COMPOSITIONS CONTAINING SAME, METHOD OF MANUFACTURE AND USE
MA30756B1 (en) CINNAMOYL-PIPERAZINE DERIVATIVES AND THEIR USE AS ANTAGONISTS BY-1
MA26701A1 (en) PYRAZOLOPYRIMIDINONES NEW PDE-5 GMPc INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MA30313B1 (en) SECONDARY AMINES AS RENIN INHIBITORS
TNSN01094A1 (en) NEW 3-AZABICYCLO [3,1,0] HEXANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM